Pneumonia News and Research

Latest Pneumonia News and Research

World Pneumonia Day 2022: Pneumonia Affects Everyone

In commemoration of World Pneumonia Day 2022, we speak to Dr. Andy Whittamore, GP and Clinical Lead at Asthma + Lung UK, about the effect pneumonia can have on everyone.

13 Nov 2022

Sociability in monkeys associated with higher abundance of beneficial gut bacteria

Social connections are essential for good health and wellbeing in social animals, such as ourselves and other primates. There is also increasing evidence that the gut microbiome – through the so-called 'gut-brain axis' – plays a key role in our physical and mental health and that bacteria can be transmitted socially, for example through touch.

11 Nov 2022

Analysis reveals highest number of pneumonia deaths in the UK

More people die from pneumonia in the UK than anywhere else in Europe, according to new analysis by leading lung charity, Asthma + Lung UK. Now, the charity is raising awareness of the signs and symptoms of pneumonia, and urging people who are eligible, such as those with severe asthma, pulmonary fibrosis and COPD, to get their one-off pneumonia vaccine.

10 Nov 2022

Surge in RSV cases – how worried should you be?

RSV hospitalizations are reaching similarly high levels much earlier than normal this year.

10 Nov 2022

A knowledgebase of currently known categorized COVID-19 severity variants

In a recent study posted to the medRxiv* preprint server, researchers assessed human genome variants related to the susceptibility and severity of coronavirus disease 2019 (COVID-19).

10 Nov 2022

What is the role of adenoviruses in human health?

With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.

9 Nov 2022

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

8 Nov 2022

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Pioneering artificial intelligence could ease winter pressures on hospitals

Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – could ease winter pressures on hospitals, University of the West of Scotland researchers believe.

7 Nov 2022

Anti-herpes drug can fight against antibiotic-resistant bacterium

A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defense mechanisms.

4 Nov 2022

A review of vaccines against the respiratory syncytial virus

This study reviewed the epidemiology, molecular characteristics, populations affected by the virus, and vaccines against RSV.

3 Nov 2022

Study sheds light on how Gram-negative bacteria construct outer membrane to resemble body armor

A new study published in the journal Science Advances sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armor, which has far-reaching implications for the development of antibiotics.

3 Nov 2022

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Researchers examined virus-virus interactions using human lung cells coinfected with two co-circulating respiratory infection-causing viruses, respiratory syncytial virus (RSV) and influenza A virus (IAV).

1 Nov 2022

Medicare fines for high hospital readmissions drop, but 2,300 facilities are still penalized

The federal government has eased its annual punishments for hospitals with higher-than-expected readmission rates in an acknowledgment of the upheaval the covid-19 pandemic has caused, resulting in the lightest penalties since 2014.

1 Nov 2022

Novel delivery system selectively delivers antibiotics to specific targets

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

1 Nov 2022

Researchers discover how hydroquinine inhibits major drug-resistant bacteria

Researchers say hydroquinine could be an effective weapon against a germ that can cause serious infections in humans, mostly hospital patients

28 Oct 2022

The epigenetic alterations of monocytes in severe COVID-19

Researchers performed DNA methylation analysis on monocytes in the peripheral blood samples obtained from severe COVID-19 patients.

28 Oct 2022

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Researchers assessed whether loss-of-function variants of type I interferon immunity genes are associated with life-threatening COVID-19.

27 Oct 2022

COVID-19 and the gut

Researchers summarize current knowledge about underlying mechanisms and potential therapeutic approaches for the effects of COVID-19 on the gut.

26 Oct 2022

A review of emerging pediatric respiratory viruses

Respiratory viruses continue to be a leading cause of childhood morbidity and mortality.

26 Oct 2022

Pneumonia News and Research

Latest Pneumonia News and Research

World Pneumonia Day 2022: Pneumonia Affects Everyone

Sociability in monkeys associated with higher abundance of beneficial gut bacteria

Analysis reveals highest number of pneumonia deaths in the UK

Surge in RSV cases – how worried should you be?

A knowledgebase of currently known categorized COVID-19 severity variants

What is the role of adenoviruses in human health?

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

Pioneering artificial intelligence could ease winter pressures on hospitals

Anti-herpes drug can fight against antibiotic-resistant bacterium

A review of vaccines against the respiratory syncytial virus

Study sheds light on how Gram-negative bacteria construct outer membrane to resemble body armor

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Medicare fines for high hospital readmissions drop, but 2,300 facilities are still penalized

Novel delivery system selectively delivers antibiotics to specific targets

Researchers discover how hydroquinine inhibits major drug-resistant bacteria

The epigenetic alterations of monocytes in severe COVID-19

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

COVID-19 and the gut

A review of emerging pediatric respiratory viruses

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in